Cargando…
Epigenetic targeting of bromodomain protein BRD4 counteracts cancer cachexia and prolongs survival
Cancer cachexia is a devastating metabolic syndrome characterized by systemic inflammation and massive muscle and adipose tissue wasting. Although it is responsible for approximately one-third of cancer deaths, no effective therapies are available and the underlying mechanisms have not been fully el...
Autores principales: | Segatto, Marco, Fittipaldi, Raffaella, Pin, Fabrizio, Sartori, Roberta, Dae Ko, Kyung, Zare, Hossein, Fenizia, Claudio, Zanchettin, Gianpietro, Pierobon, Elisa Sefora, Hatakeyama, Shinji, Sperti, Cosimo, Merigliano, Stefano, Sandri, Marco, Filippakopoulos, Panagis, Costelli, Paola, Sartorelli, Vittorio, Caretti, Giuseppina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5700099/ https://www.ncbi.nlm.nih.gov/pubmed/29167426 http://dx.doi.org/10.1038/s41467-017-01645-7 |
Ejemplares similares
-
The Prognostic Value of Low Muscle Mass in Pancreatic Cancer Patients: A Systematic Review and Meta-Analysis
por: Pierobon, Elisa Sefora, et al.
Publicado: (2021) -
Dissecting the Role of BET Bromodomain Proteins BRD2 and BRD4 in Human NK Cell Function
por: Cribbs, Adam P., et al.
Publicado: (2021) -
BETs inhibition attenuates oxidative stress and preserves muscle integrity in Duchenne muscular dystrophy
por: Segatto, Marco, et al.
Publicado: (2020) -
Bromodomains as therapeutic targets
por: Muller, Susanne, et al.
Publicado: (2011) -
9H-Purine
Scaffold Reveals
Induced-Fit Pocket Plasticity of the BRD9 Bromodomain
por: Picaud, Sarah, et al.
Publicado: (2015)